CPS (Combined Positive Score) is a scoring system for evaluating PD-L1 expression level, which combines the expression of PD-L1 on tumor cells and immune cells to provide doctors with key information about whether a patient is suitable for receiving specific immunotherapy (such as anti-PD-1/PD-L1 therapy). This evidence concerns the gene CD274 and neoplasm.